The Reduction of R1, a Novel Repressor Protein for Monoamine Oxidase A, in Major Depressive Disorder
- 8 June 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 36 (10), 2139-2148
- https://doi.org/10.1038/npp.2011.105
Abstract
The novel transcriptional repressor protein, R1 (JPO2/CDCA7L/RAM2), inhibits monoamine oxidase A (MAO A) gene expression and influences cell proliferation and survival. MAO A is implicated in several neuropsychiatric illnesses and highly elevated in major depressive disorder (MDD); however, whether R1 is involved in these disorders is unknown. This study evaluates the role of R1 in depressed subjects either untreated or treated with antidepressant drugs. R1 protein levels were determined in the postmortem prefrontal cortex of 18 untreated MDD subjects and 12 medicated MDD subjects compared with 18 matched psychiatrically normal control subjects. Western blot analysis showed that R1 was significantly decreased by 37.5% (ppp<0.05) in MAO A protein levels within the MDD groups compared with controls. Consistent with the change in MAO A protein expression, the MAO A catalytic activity was significantly greater in both MDD groups compared with controls. These results suggest that reduced R1 may lead to elevated MAO A levels in untreated and treated MDD subjects; moreover, the reduction of R1 has been implicated in apoptotic cell death and apoptosis has also been observed in the brains of MDD subjects. Therefore, modulation of R1 levels may provide a new therapeutic target in the development of more effective strategies to treat MDD.Keywords
This publication has 59 references indexed in Scilit:
- Transcription Factor E2F-Associated Phosphoprotein (EAPP), RAM2/CDCA7L/JPO2 (R1), and Simian Virus 40 Promoter Factor 1 (Sp1) Cooperatively Regulate Glucocorticoid Activation of Monoamine Oxidase BPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2010
- Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disordersInternational Journal of Neuropsychopharmacology, 2010
- A Novel Role for Glyceraldehyde-3-Phosphate Dehydrogenase and Monoamine Oxidase B Cascade in Ethanol-Induced Cellular DamageBiological Psychiatry, 2009
- Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorderJournal of Psychiatric Research, 2009
- Glyceraldehyde-3-Phosphate Dehydrogenase–Monoamine Oxidase B-Mediated Cell Death-Induced by Ethanol is Prevented by Rasagiline and 1-R-AminoindanNeurotoxicity Research, 2009
- Neurotrophin Receptor Activation and Expression in Human Postmortem Brain: Effect of SuicideBiological Psychiatry, 2008
- Differential Interaction of HIV-1 Integrase and JPO2 with the C Terminus of LEDGF/p75Journal of Molecular Biology, 2007
- The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behaviorBehavioural Pharmacology, 2007
- Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathwayProceedings of the National Academy of Sciences, 2006
- Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson?s disease and other neurodegenerative diseasesJournal of Neural Transmission, 2004